Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mehra Anand
Relationship:   Director
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   11,769,795    

Indirect Shares

   6,925,513      
Direct Value   $208,767,505    

Indirect Value

   $114,026,792      
Total Shares   18,695,308      
Total Value   $322,794,297      


Aerie Pharmaceuticals Inc $25,925 Alimera Sciences Inc $12,206 aTyr Pharma Inc $683,749 Synlogic Inc $829,972 Aclaris Therapeutics, Inc. $39,865 Iterum Therapeutics Plc $2,589,771 Principia Biopharma Inc $203,922,710 Galera Therapeutics, Inc. $663,306 Aerie Pharmaceuticals Inc $25,925 Alimera Sciences Inc $12,206 aTyr Pharma Inc $683,749 Synlogic Inc $829,972 Aclaris Therapeutics, Inc. $39,865 Iterum Therapeutics Plc $2,589,771 Principia Biopharma Inc $203,922,710 Galera Therapeutics, Inc. $663,306
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aerie Pharmaceuticals Inc AERI Director 2015-04-10 1,700 2015-04-15 469,591    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-09-12 40,020 2014-09-12 506,270    Premium*  
            Ocugen Ord Shs OCGN 10% Owner 2014-12-08 0 2014-12-08 2,077,040    Premium*  
            Spark Therapeutics, Inc. ONCE Director 2019-12-17 0 2019-12-17 0    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 1,866,126 2015-05-12 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-06 2,974,811 2015-10-05 0    Premium*  
            Aclaris Therapeutics, Inc. ACRS Director 2023-06-02 38,704 2018-10-22 1,911,573    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2018-05-30 1,726,514 2018-05-30 0    Premium*  
            Principia Biopharma Inc PRNB 10% Owner 2018-09-18 2,038,208 2018-09-18 0    Premium*  
            Galera Therapeutics, Inc. GRTX 10% Owner 2019-11-12 3,083,712 2019-11-12 0    Premium*  
            Merus Nv MRUS Director 0 2020-01-01 1,961,039    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2014-11-25 4 S $26.00 $20,800,000 I/I (800,000) 766,657 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-02-04 4 B $23.00 $5,175,000 I/I 225,000 2,118,576 2.1 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-02-04 4 A $0.00 $0 I/I 1,893,576 1,893,576 0 -
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2015-04-10 4 A $0.00 $0 D/D 1,700 1,700 0 -
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2015-04-14 4 OE $5.00 $750,000 I/I 150,000 916,657 0 -
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2015-04-14 4 S $34.08 $4,453,880 I/I (130,702) 763,889 0 -
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2015-04-14 4 D $5.00 $110,330 I/I (22,066) 894,591 0 -
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2015-04-15 4 S $33.45 $9,843,886 I/I (294,298) 469,591 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-10-07 4 S $45.56 $11,600,801 I/I (251,912) 1,866,664 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-10-08 4 S $44.38 $12,473,634 I/I (277,632) 1,589,032 0 -
ACRS Aclaris Therapeutics, Inc... Director   –       •       •   2015-10-13 4 B $11.00 $4,499,990 I/I 409,090 2,289,480 2.25 -
ACRS Aclaris Therapeutics, Inc... Director   –       •       •   2015-10-13 4 A $0.00 $0 I/I 1,880,390 1,880,390 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-11-09 4 S $60.07 $1,559,117 I/I (25,955) 1,563,077 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-11-10 4 S $60.01 $355,979 I/I (5,932) 1,557,145 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-11-11 4 S $60.13 $5,871,334 I/I (97,644) 1,459,501 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-11-12 4 S $60.00 $64,440 I/I (1,074) 1,458,427 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-11-25 4 S $60.01 $1,056,836 I/I (17,611) 1,440,816 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-11-27 4 S $60.02 $321,107 I/I (5,350) 1,435,466 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-05-31 4 AS $60.00 $30,000 I/I (500) 1,434,966 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-01 4 AS $60.03 $1,360,580 I/I (22,665) 1,412,301 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-03 4 AS $60.00 $276,720 I/I (4,612) 1,407,689 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-04 4 AS $60.00 $27,120 I/I (452) 1,407,237 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-08 4 AS $60.47 $6,047 I/I (100) 1,407,137 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-10 4 AS $60.02 $414,138 I/I (6,900) 1,400,237 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-11 4 AS $60.14 $1,387,679 I/I (23,063) 1,377,174 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us